We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Cannabis Policy

A Look Inside the Massachusetts Cannabis Testing Controversy

Two cannabis testing facilities have now been issued provisional licenses in the state but the debate over their differing approaches to microbiological contamination testing continues.

Read More

New Cannabis Regulations to Become UK Law within 2 Years

This development comes at a disruptive time for UK cannabis regulations, as the drug has only recently been moved to a schedule 2 classification under the 2001 Misuse of Drugs Regulations act, allowing clinicians to prescribe it by the fall.

Read More

UN Set to Review its Classification of Cannabis

Following the advice of the World Health Organization’s expert committee, the United Nations will launch its first ever in-depth review into the international drug classification of cannabis.

Read More

1 in 5 Cannabis Samples Are Failing California’s New Regulations

It is reported that these failures are due to both the mislabeling of products and contamination from pesticides, bacteria, and processing chemicals.

Read More

Congress Bill Submitted to End Cannabis Testing for Federal Employees

A member of the United States House of Representatives has submitted a bill to Congress which, if passed, would allow legal cannabis users to become federal employees.

Read More

Washington State Prepares for Cannabis Testing and Packaging Law Reform

A list of the proposed rule changes is expected to be published on or after October 31 2018 and will address issues like THC serving limits, packaging requirements, and contaminant testing.

Read More

Association of Cannabis Specialists Publishes 8 Steps to U.S. Federal Cannabis Legalization

With only a patchwork of state cannabis laws currently in existence, these new recommendations offer a unified federal framework to help optimize the care of patients across the country.

Read More

Experts Claim Proposed Californian Cannabis Regulations Could Put Medical Cannabis Users at Risk of Infection

Californian cannabis users could be put at serious risk from fungal and bacterial contaminants as new regulations lack effective safety screenings, despite the state’s Quality Control Committee specifically advocating for such tests.

Read More

American Osteopathic Association Declares Support for Review of Medical Cannabis

The American Osteopathic Association supports the reclassification of cannabis as a Schedule II Drug to facilitate advancement in clinical, public health, patient safety and health policy research, according to a resolution approved by the AOA House of Delegates.

Read More

 
Advertisement